| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 722222 | Null | 0.0459335986102865 | -0.05931327 |
| NSC 724631 | 4,11-dihydroxy-1-[4-[[2-hydroxy-1-(hydroxymethyl)-1-methylet hyl]-mino]butyl]-1H-naphtho[2,3-f]indole-5,10-dione | 0.0459335986102865 | 0.056151512 |
| NSC 735540 | 5-fluoro-N-(2-methyl-3-oxo-8-phenyl-1-thia-4-azaspiro[4.5]de c-4-yl)-3-phenyl-1H-indole-2-carboxamide | 0.0459335986102865 | 0.10160342 |
| NSC 736200 | 6-(3-Bromopropyl)-5,6-dihydro3-nitro-5,11-dioxo-9-thiomethyl -11H-indeno[1,2-c]isoquinoline | 0.0459335986102865 | 0.50566247 |
| NSC 736493 | Indenoisoquinoline derivative | 0.0459335986102865 | 0.57544406 |
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.0459335986102865 | 0.047092215 |
| NSC 744331 | (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd | 0.0459335986102865 | 0.087640871 |
| NSC 756166 | GSK312948A | 0.0459335986102865 | 0.33230185 |
| NSC 759216 | (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone | 0.0459335986102865 | 0.023649788 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0459335986102865 | 0.40875239 |